MedPath

On Site Sensors Monitoring Impacts of Cognitive Decline on ADLs

Conditions
Dementia
Dementia Alzheimers
Registration Number
NCT04871698
Lead Sponsor
National Institute on Aging (NIA)
Brief Summary

The purpose of this research is to compare the effectiveness of a continuous monitoring system to assess Activities of Daily Living (ADLs) over time compared to the traditional assessments used by medical professionals as Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD) progresses.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
140
Inclusion Criteria
  • Fluent in English to understand and sign the consent or assent documents.
  • Adult over 65 years of age with no children under 18 years old living in residence.
  • Adult anticipates they will be living primarily at designated residence over next 18 months.
  • Must receive caregiver interaction at least 6 hours/week.
  • Must undergo a Mini-Mental State Exam (MMSE) assessment at baseline during recruitment as well as at the end of the study with a resulting score of 11-25 as part of the recruitment phase of the study.
  • Must be willing to have home or facility equipped with sensors to obtain activity and location data.
Exclusion Criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Demonstrate equivalency of the proposed IoT system against ADCS-ADL/23 Assessment18 months

The ADCS-ADL/23 assessment will be utilized to measure changes in activities of daily living in the sample population while BC's system is also in place independently measuring the changes in activities of daily living.

Identify improved sensitivities for detection of early and moderate-stage AD/ADRD activities of daily living changes18 months

AI techniques will search sensor data for subfactor and novel groupings for statistically significant improvements from what is measured by the ADCS/ADL-23 assessment of decline.

Secondary Outcome Measures
NameTimeMethod
Establish initial data sets and protocols for use of the developed ADL/IADL system data for integration with AD/ADRD research18 months

Database structures and meta-data will be established for anonymous data sets.

Trial Locations

Locations (1)

Birkeland Current

🇺🇸

Waco, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath